Abbott India
ABBOTINDIA · Pharma > Pharmaceuticals & Drugs · Chairman: Munir Shaikh Listing date: Jan. 9, 2010 · Employees: 3585 · Mumbai · http://www.abbott.co.in

Stock Price vs Company Growth
1d
3.0%
1w
4.3%
1m
9.3%
3m
8.2%
6m
2.9%
1y
5.5%
5y
14.6%
10y
24.1%
all
28.4%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowSep08Dec11Mar15Jun18Sep21Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

29,822 3.0%
25,260
30,683
Company Overview

Sales
6,243 Cr
Growth: 7.9%
Profit after Tax
1,334 Cr
Growth: 3.9%
Large Cap
63,369 Cr
P/E: 47.5x
Industry P/E: 29.8x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 6,243
Growth 7.9%
EBITDA 25.6%
P/S 10.2x
Dividend 0.8%
P/E 47.5x
Book Value ₹ 2,234
PEG Ratio 6.0x
ROE 31.7%
P/B 13.4x
Shareholding Pattern

Institutions
Life Insurance Corporation Of India
1.64 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Sep21
Promoters
Abbott Capital India Limited
50.44 %
Abbott Healthcare Products Limited
17.62 %
British Colloids Limited
6.92 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Sep21
Others
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Sep21
Increase    Decrease    No change
Company Profile Detailed

The company is one of the leading multinational pharmaceutical companies in India and operates with owned manufacturing units and various independent contract/third party manufacturers based across the country. The company sells its products through independent distributors primarily within India.Products and Services offered by the companyCardiovascular- Keeping heart healthy with breakthrough medical technologies.Diabetes- Helping people with diabetes enjoy healthier, active lives.
Investors (50)
Followers (16)